An Alabama-based doctor has been charged and has agreed to plead guilty in connection with a $6 million telemedicine fraud scheme, federal prosecutors in Massachusetts announced on August 18, 2025. The scheme involved medically unnecessary durable medical equipment (DME) and genetic testing, primarily used to detect cancer-related gene mutations.
According to charging documents, between December 2018 and March 2021, the doctor collaborated with telemedicine companies to sign off on medical documentation, including doctors’ orders, for DME and genetic testing that were not medically necessary. Prosecutors allege the orders were pre-populated based on telemarketing calls to Medicare beneficiaries. The doctor reportedly had no contact with the patients and no established medical relationship with them.
DME suppliers and laboratories used the signed orders to submit claims to Medicare. As a result, more than $6 million in false claims were submitted for reimbursement, based on fraudulent documentation and tainted by kickbacks.
If convicted, the doctor faces up to 10 years in prison for healthcare fraud, up to three years of supervised release, and a fine of $250,000 or twice the financial gain or loss, whichever is greater.
Compliance Perspective
Issue
Telemedicine has become a standard mode of care delivery across many healthcare settings, offering increased access and efficiency. However, its expanded use continues to present compliance risks—particularly when providers sign orders for durable medical equipment (DME) or laboratory testing without a valid clinical relationship or documented medical necessity. Such practices may lead to the submission of false claims and expose providers and organizations to liability under the False Claims Act, Anti-Kickback Statute, and other federal regulations. Organizations must ensure telemedicine services are delivered in accordance with applicable laws and accepted standards of care.
Discussion Points
- Review and update policies and procedures to ensure that all telemedicine services are supported by documented clinical evaluations, valid practitioner-patient relationships, and independent medical judgment. If needed, consider engaging an external consultant to assist with policy development or conduct a focused review of current protocols to ensure they meet regulatory standards.
- Provide regular training to staff on the appropriate use of telemedicine, fraud prevention, and documentation standards. Med-Net Academy offers Fraud Module 10 – Vendor Contracts, which covers adherence to vendor contracting policies, Medicare billing requirements, and government contracting elements.
- Conduct periodic audits of telemedicine services, including DME and lab orders, to identify potential compliance concerns and ensure all claims are properly supported. In addition to internal reviews, organizations may benefit from an objective assessment performed by a third-party consultant, especially one experienced in conducting mock surveys or focused reviews related to telemedicine practices.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*